BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34228946)

  • 1. Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia.
    Zhou H; Zhao G; Li Y
    Clin Exp Optom; 2022 Jul; 105(5):520-526. PubMed ID: 34228946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
    Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to slow progression of myopia in children.
    Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
    Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A
    BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kaburaki T; Kakehashi A
    Sci Rep; 2020 Jul; 10(1):12750. PubMed ID: 32728111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Administration of 0.02% Atropine and Orthokeratology for Myopia Control.
    Lyu Y; Ji N; Fu AC; Wang WQ; Wei L; Qin J; Zhao BX
    Eye Contact Lens; 2021 Feb; 47(2):81-85. PubMed ID: 32443010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
    Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
    JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents.
    Tang T; Lu Y; Li X; Zhao H; Wang K; Li Y; Zhao M
    Eye (Lond); 2024 Jun; 38(9):1660-1667. PubMed ID: 38418604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.
    Gao C; Wan S; Zhang Y; Han J
    Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
    Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
    PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trial.
    Xu S; Li Z; Zhao W; Zheng B; Jiang J; Ye G; Feng Z; Long W; He L; He M; Hu Y; Yang X
    Br J Ophthalmol; 2023 Nov; 107(12):1812-1817. PubMed ID: 36229177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
    Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
    Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study.
    Chen Z; Huang S; Zhou J; Xiaomei Q; Zhou X; Xue F
    Cont Lens Anterior Eye; 2019 Aug; 42(4):439-442. PubMed ID: 30482510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for myopia control in children: a living systematic review and network meta-analysis.
    Lawrenson JG; Shah R; Huntjens B; Downie LE; Virgili G; Dhakal R; Verkicharla PK; Li D; Mavi S; Kernohan A; Li T; Walline JJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD014758. PubMed ID: 36809645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Atropine 0.01% Eye Drops on the Difference in Refraction and Axial Length between Right and Left Eyes.
    Liang X; Wei S; Li SM; An W; Du J; Sun Y; Gan J; Bai W; Cai Z; Song Q; Yin L; Wang N
    Ophthalmic Res; 2023; 66(1):496-505. PubMed ID: 36603556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atropine for the treatment of childhood myopia.
    Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
    Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myopia progression and axial elongation in Spanish children: Efficacy of atropine 0.01% eye-drops.
    Moriche-Carretero M; Revilla-Amores R; Diaz-Valle D; Morales-Fernández L; Gomez-de-Liaño R
    J Fr Ophtalmol; 2021 Dec; 44(10):1499-1504. PubMed ID: 34774348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
    Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
    BMC Ophthalmol; 2023 Oct; 23(1):438. PubMed ID: 37904082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of atropine 1% in children with low myopia.
    Yi S; Huang Y; Yu SZ; Chen XJ; Yi H; Zeng XL
    J AAPOS; 2015 Oct; 19(5):426-9. PubMed ID: 26228967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Clinical Efficacies of 0.01% Atropine and Orthokeratology in Controlling the Progression of Myopia in Children.
    Zhao Q; Hao Q
    Ophthalmic Epidemiol; 2021 Oct; 28(5):376-382. PubMed ID: 33472507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.